ResultsIQ › Latest results › Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited investor presentation summary
NSE: GKSL · BSE: 544666
Investor presentation of 27 Aug 2026, summarised by AI from the filing.
Management will attend GIA Healthcare Day with investors and analysts on 31 August 2026.
Key takeaways
- Meeting Management will attend GIA Healthcare Day with investors and analysts on 31 August 2026 at Jio World Convention Centre, BKC.
- Disclosure The company will refer only to publicly available documents and no unpublished price sensitive information is intended to be discussed.
- IR agency The company recently engaged Go India Advisors as its Investor Relations and PR agency.
- Short notice The company decided to participate in the healthcare conclave on an urgent basis and on shorter notice.
- Schedule The schedule is indicative and subject to change due to unforeseen developments or exigencies.
Gujarat Kidney And Super Speciality Limited Q1 FY27 results
As filed: Revenue ₹34.3 cr, EBITDA ₹8.4 cr, PAT ₹5.3 cr, EBITDA margin 24.4%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹34.3 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹30.6 cr, EBITDA ₹6.3 cr, PAT ₹4.8 cr, EBITDA margin 20.6%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.6 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −5.0% in 28 days (Nifty 500: +0.6%).
- Q3 FY26: Revenue ₹23.3 cr, EBITDA ₹6.9 cr, PAT ₹3.7 cr, EBITDA margin 29.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹23.3 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −4.2% in 30 days (Nifty 500: −7.8%).
Past price moves after results do not indicate future moves. Not a recommendation.
Gujarat Kidney And Super Speciality Limited earnings call, investor presentation and press release summaries
- Other events: Investor presentation (27 Aug 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.